Go Back   Anonymous Bodybuilding > The Anti-Aging/Smart-Drug Forum > Novel Drugs and Supplements
Donate

Novel Drugs and Supplements for bodybuilding and general health

Ron Paul 2008 - There Is No Hope Left
Reply
 
LinkBack Thread Tools Display Modes
  #1  
Old 05-25-2006, 10:10 PM
The Anonymizer's Avatar
The Anonymizer The Anonymizer is online now
Administrator
 
Join Date: Jan 2006
Posts: 4,664
The Anonymizer has disabled reputation
Send a message via AIM to The Anonymizer
Default Pentoxyfilline - Enhance Healing, Circulation, and Reduce Inflamation

Pentoxifylline
The Elephant Formulary
© 2003-05 Susan K. Mikota DVM and Donald C. Plumb, Pharm.D.
Published by Elephant Care International -
www.elephantcare.org


Elephant specific information, if available, is in blue.
Chemistry/Storage/Stability/Compatibility - A synthetic xanthine derivative structurally related to caffeine and theophylline, pentoxifylline occurs as a white, odorless, bitter-tast­ing, crystalline powder. At room temperature, approximately 77 mg are soluble in one ml of water and 63 mg in one ml of alcohol.The commercially available tablets should be stored in well-closed containers, protected from light and at 15-30°C. Pentoxifylline is also known as oxpentifylline or BL-191.
Pharmacology - The mechanisms for pentoxifylline’s actions are not fully understood. The drug increases erythrocyte flexibility probably by inhibiting erythrocyte phosphodi­esterase and decreases blood viscosity by reducing plasma fibrinogen and increasing fibri­nolytic activity.
Pentoxifylline is postulated to reduce negative endotoxic effects of cytokine mediators via its phosphodiesterase inhibition.
Uses/Indications - In horses, pentoxifylline has been used as adjunctive therapy for endo­toxemia and in the treatment of navicular disease. At the time of writing, the drug is still under investigation to document both safety and efficacy for these purposes.
Pentoxifylline has been used in dogs to enhance healing and reduce inflammation caused by ulcerative dermatosis in Shelties and Collies and for other conditions where improved microcirculation may be of benefit.
Pentoxifylline’s major indications for humans include symptomatic treatment of periph­eral vascular disease (e.g., intermittent claudication, sickle cell disease, Raynaud’s, etc.) and cerebrovascular diseases where blood flow may be impaired in the microvasculature.
Pharmacokinetics - A pharmacokinetic study done in horses showed high interpatient variability in absorption of oral dosage forms with peak levels occurring 1 - 10 hours after oral dosing. No significant difference in relative bioavailability was noted between whole and crushed extended-release tablets. The drug appears to rapidly eliminated (half life of about one hour after IV dosing). Because of the wide interpatient variability, the authors were unable to make dosing recommendations for clinical use.
In humans, pentoxifylline absorption from the gastrointestinal tract is rapid and almost complete, but a significant first-pass effect occurs. Food affects the rate, but not the extent of absorption. While the distributive characteristics have not been fully described, it is known that the drug enters maternal milk. Pentoxifylline is metabolized both in the liver and in erythrocytes and all identified metabolites appear to be active.
Contraindications/Precautions/Reproductive Safety - Pentoxifylline should be consid­ered contraindicated in patients who have been intolerant to the drug or xanthines (e.g., theophylline, caffeine, theobromine) in the past and those with cerebral hemorrhage or retinal hemorrhage. It should be used cautiously in patients with severe hepatic or renal impairment and those at risk for hemorrhage.
Although safety in pregnant, lactating or breeding animals has not been established, stud­ies in pregnant rats and rabbits demonstrated no overt teratogenicity. As pentoxifylline and its metabolites enter maternal milk, benefits to the mother should be weighed against the risks to offspring.
Adverse Effects/Warnings - Most commonly reported adverse effects involve the GI tract (vomiting/inappetence). There are reports of dizziness and headache occurring in a small percentage of humans receiving the drug. Other adverse effects, primarily GI, CNS and cardiovascular related have been reported in people, but are considered to occur rarely. Note: Veterinary experience is limited with pentoxifylline and animal adverse ef­fects may differ.
Overdosage - Humans overdosed with pentoxifylline have demonstrated signs of flushing, seizures, hypotension, unconsciousness, agitation, fever, somnolence, GI distress and ECG changes. One patient who ingested 80 mg/kg recovered completely. Overdoses should be treated using the usual methods of appropriate gut emptying and supportive therapies.
Drug Interactions - Use of non-steroidal antiinflammatory agents with pentoxifylline in horses is controversial. Some sources state that when used for endotoxemia in horses, pen­toxyfilline’s beneficial effects are negated by NSAIDs, but one study showed superior ef­ficacy when flunixin and pentoxifylline were used together compared with either used alone. Ciprofloxacin (other quinolones too?) and cimetidine can increase pentoxifylline serum levels. Increased adverse effects of pentoxifylline may result. When pentoxifylline is used with warfarin or other anticoagulants, increased risk of bleeding may result. Use together with enhanced monitoring and caution. Theophylline blood levels may be increased when used concurrently with pentoxifylline.
Doses -
Horses:
a) To reduce the cytokine effects in endotoxemia: 8.5 mg/kg PO bid (considered to be experimental therapy) (Edens and Cargile 1997)
b) For treatment of navicular disease: 6 grams per day PO for 6 weeks (Livesay 1996)
Monitoring Parameters - Efficacy and adverse effects
Client Information - To reduce the GI effects of pentoxifylline, give with food. Clients should understand that veterinary experience with this medication is limited and that the risk versus benefit profile is not well defined.
Dosage Forms/Preparations/FDA Approval Status -
Veterinary-Approved Products: None
Human-Approved Products:
Pentoxifylline 400 mg extended-release tablets (pink); Trental® Tablets (Hoechst Marion Roussel), Generic; (Rx)
__________________
Welcome to the most secure board on the web.

No hidden agendas.
No Mods I don't know personally.
No sources with multiple handles.
No mysterious post deletions.
No selling or post-whoring to VIP status.
PGP use encouraged.

...oh yeah, and no VinDiesel or "alliance" with homo boards.

Check out the AnonBB Supersite at www.anonymousbodybuilding.com and our new sister sites:

www.steroid-sources.com
www.sub-q.com
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
  #2  
Old 10-08-2006, 07:02 PM
AKA PHARMS.(PITBULL)'s Avatar
AKA PHARMS.(PITBULL) AKA PHARMS.(PITBULL) is offline
BUSTED
 
Join Date: Apr 2006
Posts: 191
AKA PHARMS.(PITBULL) is an unknown quantity at this point
Question ANYONE USE THIS PRODUCT HERE?

HAS ANYONE BEEN A TEST RAT YET WITH THIS STUFF?
IF SO WHATS YOUR THOUGHTS AND EXP.?
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
  #3  
Old 10-08-2006, 09:25 PM
Born2Juice4Ever's Avatar
Born2Juice4Ever Born2Juice4Ever is offline
Active Member
 
Join Date: Apr 2006
Location: Thinking Of How Irrisistable She Is, You?
Posts: 451
Born2Juice4Ever is an unknown quantity at this point
Thumbs up

We need to get a chemist on the task and make this for us/./ sounds extremelly promising. I have only scanned quickly, but will come back to read and research more.


If it has not been approved by the FDA than that can only mean that it is available but the source not easily found perhaps. Nom' sayin'?

B2J
__________________


Some Brothers are Born...others EARN it.
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
Reply


Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On




All times are GMT. The time now is 09:06 PM.



Powered by vBulletin® Version 3.6.7



YOU HEREBY ACKNOWLEDGE THAT YOU ARE AT LEAST EIGHTEEN YEARS OF AGE (18). USE OF THIS WEB SITE IS INTENDED FOR ADULTS ONLY. This WEB SITE provides users with information of all kinds and types regarding anabolic and/or androgenic steroids as well as human growth hormone, IGF1, and other substances pertaining to bodybuilding. This WEB SITE does not recommend that ANYONE use anabolic and/or androgenic steroids or other substances pertaining to bodybuilding such as, but not limited to the following: testosterone, nandrolone / deca-durabolin, oxymetholone / anadrol, methenolone / primobolan, oxandrolone / anavar, stanazolol / winstrol, boldenone / equipoise, methandrostenolone / dianabol,fluoxymesterone / halotestin,furazabol,bolasterone,epistane / havoc / hemoguno,clenbuterol,cytomel,human growth hormone / HGH,melanotan, It is an information providing WEB SITE only. THE USE OF STEROIDS WITHOUT A DOCTORS PRESCRIPTION IS A VIOLATION OF FEDERAL LAW. IN ADDITION THE USE OF STEROIDS OR ANY DRUG WITHOUT A DOCTORS PRESCRIPTION AND/OR INSTRUCTION CAN AND MAY HAVE SEVERE SIDE EFFECTS TO YOUR HEALTH UP TO AND INCLUDING DEATH. THE USE OF THE WEB SITE AND THE FOLLOWING OF OR USE OF ANY INFORMATION APPEARING ON THE WEB SITE IS SOLELY AND EXCLUSIVELY AT YOUR OWN RISK. BY ACCEPTING THESE TERMS AND ACKNOWLEDGING YOUR ACCEPTANCE BELOW YOU THE USER EXPLICITLY ACKNOWLEDGE THAT YOU HAVE BEEN MADE AWARE AND AGREE THAT YOU WILL NOT IN ANY WAY HOLD THE COMPANY RESPONSIBLE, NOR WILL ANYONE ON YOUR BEHALF HOLD THE COMPANY RESPONSIBLE, FOR ANY USE OF THE INFORMATION OR MATERIAL CONTAINED ON THIS WEB SITE. Changes are periodically made to the Web Site and may be made at any time. YOU AGREE TO DEFEND, INDEMNIFY, AND HOLD HARMLESS THE COMPANY, ITS OFFICERS, DIRECTORS, EMPLOYEES AND AGENTS, FROM AND AGAINST ANY CLAIMS, ACTIONS OR DEMANDS, INCLUDING WITHOUT LIMITATION REASONABLE LEGAL AND ACCOUNTING FEES, BROUGHT BY YOU, SOMEONE ON YOUR BEHALF OR ANY OTHER INDIVIDUAL OR ENTITY, ALLEGING HARM OR DAMAGE OF ANY KIND, BE IT TO PROPERTY OR TO PERSON, RESULTING FROM YOUR USE OR ALLEGED USE OF THE MATERIAL OR INFORMATION ON THE WEB SITE (INCLUDING SOFTWARE) OR YOUR BREACH OF THE TERMS OF THIS AGREEMENT.

Search Engine Friendly URLs by vBSEO 3.0.0

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104